Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Njia ya Chou-Talalay× | Uundaji wa Kimodelia wa Madhara ya Dawa kwa Idadi ya Watu× | |
|---|---|---|
| Nyanja | Famakolojia | Famakolojia |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 1983 | 1992 |
| Mwanzilishi≠ | Ting-Chao Chou and Paul Talalay | Lewis Sheiner and Stephen Roush |
| Aina≠ | synergy quantification | dose-response modeling |
| Chanzo asilia≠ | Chou, T. C., & Talalay, P. (1983). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27-55. DOI ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| Majina mbadala | CI method, Chou method, median-effect analysis | PopPD, population PD, hierarchical PD modeling |
| Zinazohusiana | 3 | 3 |
| Muhtasari≠ | The Chou-Talalay method is a quantitative framework for analyzing drug interactions, developed by Ting-Chao Chou and Paul Talalay in 1983. It combines median-effect principle with the combination index (CI) to provide rigorous, model-independent assessment of synergistic, additive, or antagonistic drug effects. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGateSeti ya data ↗ |
|
|